Pharma / Medical

Thlala Kolo Limited is one of the fastest growing veterinary pharmaceutical companies in the Agro-veterinary industry in Nigeria with a multi-talented business marketing team spread across the 36 states of the Federation and the FCT. The Company, at the moment, services over 500 happy customers in Nigeria. It came into existence in the year 2008 and a year later emerged as the sole Nigerian distributor of Interchemie werken "De Adelaar" BV, an offshore GMP Veterinary Products Manufacturer based in Holland. Thlala Kolo Limited is one of the fastest growing veterinary pharmaceutical companies in the Agro-veterinary industry in Nigeria with a multi-talented business marketing team spread across the 36 states of the Federation and the FCT. The Company, at the moment, services over 500 happy customers in Nigeria. It came into existence in the year 2008 and a year later emerged as the sole Nigerian distributor of Interchemie werken "De Adelaar" BV, an offshore GMP Veterinary Products Manufacturer based in Holland. With over 33 years of active business experience and consistent production of a matchless array of efficacious veterinary products, Interchemie possesses a huge share of the global veterinary pharmaceutical market as showcased by her presence in more than 95 (Ninety-five) countries worldwide, making our union a force to reckon with in the Agro-veterinary industry. Our emergence was borne out of the belief that the nation needs to re-focus on agriculture to make it once again the mainstay of the economy in the foreseeable future with a latent intent to participate actively in the soon-to-be born Nigeria's revolution in the Agro-Veterinary sector. At Thlala Kolo Limited, we parade a management team made up of core professionals saddled with active drive to put to use their prowess and respective experiences acquired in diverse professions, including but not limited to farming, medicine, management, pharmacy and technology, towards building an organization that will answer the clarion call for the provision of effective, reputable, affordable and readily available veterinary products of high quality, requisite for a productive Agro-veterinary Industry.

Key Oncologics (Pty) Ltd is a South African pharmaceutical company that primarily focuses on the treatment of cancer and allied diseases. The company was founded in 1998 representing international companies that do not have an independent presence in South Africa. Over the years our product profile has grown from a single product to a comprehensive portfolio. We have also diversified into biologics and are in the process of building a generic portfolio. In moving forward Key Oncologics will continue to seek options for patients to live longer and live better. Key Oncologics (Pty) Ltd has experience in registering, marketing, selling and distributing cancer products in the South African market. We also have a clinical trial division with the necessary infrastructure to conduct Oncology Clinical Trials according to GCP.

Hersol Manufacturing Laboratories is a fully licensed and registered pharmaceutical manufacturing company and was founded in 1980. Today Hersol is one of the leading Pharmaceutical Contract Manufacturing Companies within the South African Market. Hersol specialises in the development and manufacture of Complementary Medicines, Nutritional Supplements and Pharmaceuticals. Hersol prides itself on producing quality products through a carefully managed Total Quality Management System governing all activities, especially so as to lead the way in the Complementary Medicines and Nutritional Supplement market. The company has acquired a reputation for consistent good quality, price, service and delivery, which is indicated by the fact that we hold a full pharmaceutical manufacturing license, which is re-assessed regularly by the South African Medicine Control Council. With Hersol manufacturing large volumes of supplements the R & D (Research and Development) department is an important contributor of new ideas and concepts that potentially add value to customers’ businesses. Close collaboration with raw material suppliers ensures that the very latest and highest quality ingredients are available for incorporation into prototype formulations, further adding value to the supply chain. As a result of the integrated Total Quality Management system, embracing first and foremost, Good Manufacturing Practices (GMP) and strict Quality Control Procedures, the best quality of both raw materials and finished product is ensured. This facility complies with the Medicine Control Council (MCC) Code of Good Manufacturing Practice (GMP), a standard of manufacturing excellence recognized throughout the Industry. Hersol maintains a watchful eye on world trends and then improves and innovates to deliver leading edge products to its customer base. This intimate market knowledge is gained through regular travel by Hersol’s Management team to major world markets.

Reals Group started as Reals Pharmaceuticals Limited, a company that commenced its operation as the local scientific and marketing office of Zeneca Pharmaceuticals Limited, now AstraZeneca U.K. Today, the scope of our operations has extended beyond just being the local scientific and marketing office for AstraZeneca to becoming the sole Nigeria representative and distributor of a number of other first class pharmaceutical industries in the world. Reals Pharmaceuticals Limited was one of the first pharmaceutical companies to successfully commence the local scientific and marketing office in Nigeria. In 1996, the idea of scientific and marketing office was new to the pharmaceutical industry. It nevertheless required creative thinking, determination, courage and patience to implement. The company was incorporated as a limited liability company in August 1995. It started operations on January 2nd 1996, with a team of six, comprising of the General Manager, Pharm, Ade Popoola and five medical representatives. The new millennium has come with its various challenges, one of which is the very dynamic business environment. To meet these challenges, the group has gone into strategic alliance with some companies both within and outside Nigeria for contract manufacturing arrangement to manufacture REALS range of ethical and consumer healthcare pharmaceutical brands. On October 10th 2008 the group relocated to its own purposely built corporate headquarters, REALS PLAZA, located at Plot 1 Junaid Dosunmu Street, Central Business District, Alausa, Ikeja, Lagos. Hitherto, its head office was situated at All Seasons Plaza, Agidingbi, Ikeja. Reals group is a very relevant and active player in the Nigerian very competitive pharmaceutical market, possessing both spread and reach in the very vast and fertile Nigerian business terrain. Our sales and medical representatives are spread across all the six geo-political zones that make up the nation Nigeria.

Continental Pharma Care Group, CPCG, is committed to improving the health and wellness of the people in the Republic of South Sudan and the greater East African community. We distribute and sell high-quality generic prescription and non-prescription (OTC) drugs, healthcare products, and healthcare services. We are able to offer quality products at low prices by forging partnerships with well-established international companies, governmental and non-governmental organizations who understand the mission of providing affordable healthcare to the poor segments of the population in this region. Our dedicated, experienced, and well-trained cadre of managerial and professional staff works hard to reduce overhead costs and enhance supply-chain efficiencies. T he East African region faces acute shortages of prescription drugs and basic healthcare services, especially for those at the bottom of the economic pyramid. For this population, the health indicators are grim. Infant and maternal mortality rates are among the highest in the world. The number of people dying from preventable and treatable diseases continues to increase at an alarming rate. The average life expectancy hovers around 45 years. These grim statistics call for approach to combating the problem, one that emphasizes building public-private partnership and improving supply-chain efficiencies in order to deliver medicine and healthcare services to those in need, at affordable prices. The grim mortality statistics call for approach that emphasizes building public-private partnership and improving supply-chain efficiencies in order to deliver medicine and healthcare services to those in need at affordable prices. These are achieved by entering into partnerships with global producers and distributors of generic pharmaceutical products and bio-tech companies, as well as leveraging linkages with other governmental and non-governmental organizations in the region. This business model enables CPCG and its partners to serve this population at a sustaining level of profitability.